About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Seminars in Liver Disease
›
Top Articles
Seminars in Liver Disease
Hepatology
7.3
(top 1%)
Impact Factor
7.8
(top 1%)
extended IF
137
(top 2%)
H-Index
400
authors
1.6K
papers
96.6K
citations
5.3K
citing journals
33.6K
citing authors
Most Cited Articles of Seminars in Liver Disease
Title
Year
Citations
Prognosis of hepatocellular carcinoma: the BCLC staging classification
1999
2.7K
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
2010
2.5K
The epidemiology of cholangiocarcinoma
2004
912
Macrophages: master regulators of inflammation and fibrosis
2010
878
Resection and liver transplantation for hepatocellular carcinoma
2005
878
Current strategy for staging and treatment: the BCLC update and future prospects
2010
770
Epidemiology of primary liver cancer
1999
763
Epidemiology of hepatitis C: geographic differences and temporal trends
2000
704
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes
1995
643
Nonalcoholic steatohepatitis: definition and pathology
2001
630
Pharmacological treatment of portal hypertension: an evidence-based approach
1999
608
Overview of microRNA biology
2015
584
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome
2000
562
History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells
2001
558
The epidemiology of nonalcoholic fatty liver disease: a global perspective
2008
547
Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)
2002
477
Fulminant and subfulminant liver failure: definitions and causes
1986
477
Etiopathogenesis of nonalcoholic steatohepatitis
2001
467
Genomics and signaling pathways in hepatocellular carcinoma
2007
425
Clinical features and natural history of nonalcoholic steatosis syndromes
2001
418
Matrix as a modulator of hepatic fibrogenesis
2001
404
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
2008
393
Extracellular matrix degradation and the role of hepatic stellate cells
2001
393
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
2008
388
Hepatic stellate cells as a target for the treatment of liver fibrosis
2001
388
previous
1992
1993
1994
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.